Patient Guide: Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 300 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04524611
Status: ACTIVE_NOT_RECRUITING
Condition: Crohn's Disease (CD)
Phase: PHASE3

Find a Study Location Near You

This study is available at 300 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Chandler, Arizona
  • Coronado, California
  • Irvine, California
  • • And 297 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily